LIM
AMRI

Longfellow Investment Management’s Albany Molecular Research Inc AMRI Stock Holding History

Longfellow Investment Management’s Portfolio AMRI Stock Details AMRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-275,000
Closed -$5.97M – 85
2017
Q2 		$5.97M Buy
+275,000
New +$4.99M 1.72% 26

Other funds holding AMRI

AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Longfellow Investment Management's AMRI Position: Q3 2017 in Review

Longfellow Investment Management sold out of Albany Molecular Research Inc (AMRI) in Q3 2017, closing a stake of 275,000 shares — an estimated $5.97M sold.

Longfellow Investment Management first reported a position in AMRI in Q2 2017 and held it in 1 quarter. The position peaked at $5.97M in Q2 2017. 2 funds tracked by Wall St. Rank hold AMRI as of Q3 2017.

  • Longfellow Investment Management reported no remaining Albany Molecular Research Inc position as of Q3 2017 after selling out during the quarter.
  • Longfellow Investment Management sold 275,000 Albany Molecular Research Inc shares in Q3 2017, an estimated $5.97M.
  • Longfellow Investment Management first reported a position in Albany Molecular Research Inc in Q2 2017 and held it in 1 quarter.
  • Longfellow Investment Management's Albany Molecular Research Inc position peaked at $5.97M in Q2 2017.
  • 2 funds tracked by Wall St. Rank held Albany Molecular Research Inc as of Q3 2017.

Based on Longfellow Investment Management's 13F filing for Q3 2017, filed 20 Oct 2017.